STD Diagnostics Market, By Type (Syphilis Testing, Chlamydia Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Chancroid Testing, Human Papilloma Virus Testing, and Human Immunodeficiency Virus Testing), By Testing Device (Point of Care (PoC) Devices, and Laboratory Devices), By Testing Location (Point of Care (PoC) Testing, and Laboratory Testing) and By Geography (EU, NA, APAC, LATAM, and MEA) Analysis, Size, Share, Trends, & Forecast from 2020-2026
- Published Date: 2020-10-13
- Report ID: 1815
- Pages: 216
-
Format:
REPORT HIGHLIGHT
Sexually Transmitted Disease (STD) diagnostics market was valued at USD 156.8 billion by 2019, expanding at 7.9% CAGR during the study period, 2020-2026.
Sexually transmitted diseases (STD) are infectious disease, caused due to person to person sexual contact. It is stated that more than 30 viruses, bacteria, and parasites are transmitted through sexual contact. The infection may develop infections such as Human Immunodeficiency Virus (HIV) infections, syphilis, Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV) which causes mild to severe life-threatening symptoms. The infection can transmit person to person, hence STD diagnosis plays a vital role in the prevention and treatment of such conditions. As per the study conducted by the National AIDS Control Organization, early diagnosis of STDs and proper management can help to reduce the HIV-1 infection by 40% to the general population.
Market Dynamics
The increasing prevalence of STDs is considered to be the major driving factor for industry growth. According to the World Health Organization (WHO), more than one million STDs are acquired every year worldwide. Thus, the demand for effective and accurate diagnostic methods is set to increase, driving market growth. Following to this, companies are actively investing in research activities to develop new testing methods for an accurate diagnosis. The commercial availability of immunochromatographic tests (ICT) all over the world is considered to create lucrative growth opportunities in this market. This testing technique is one of the most sensitive, affordable, and user-friendly advanced method of diagnosis which can provide results within 1520minutes.
Rising U.S. FDA approved testing kits is projected to further fuel market development. For instance, in May 2019, the U.S. FDA approved two tests that can detect the presence of Neisseria gonorrhoeae and bacteria Chlamydia trachomatis. The Xpert CT/NG and Aptima Combo 2 Assay are the two devices cleared by the regulatory body for extragenital diagnostic testing via the rectum and throat. In addition, other factors such as favorable government initiatives, growing awareness, and knowledge of sexual diseases coupled with new drug discoveries will support the overall market growth. Conversely, lack of awareness in the developing regions is predicted to impede the industry growth to some extent.
Types Takeaway
Depending upon types, the worldwide STD Diagnostics market is categorized into Syphilis, Chlamydia, Gonorrhea, Chancroid, Herpes Simplex Virus, Human Immunodeficiency Virus, and Human Papilloma Virus testing. Out of these, the Chlamydia testing category accounted for the highest revenue share, over 34% share in 2019. Chlamydia is the most commonly occurring STDs and can be treated by antibiotic medications such as erythromycin and azithromycin. In addition, a rise in the prevalence of this infection among pregnant women is anticipated to increase the rate of chlamydia screening, supporting the segment growth.
On the other hand, Syphilis screening is projected to grow with the fastest growth rate during the study period. As per the Centers for Disease Control and Prevention (CDC), there were more than 115,000 reported new diagnoses of all stages of syphilis in the U.S. alone and the number is increasing. The growing rate of anonymous sex, rising number of unprotected sex, sex with multiple partners and under the influence of several therapeutics will support the growth this category.
Testing Device Takeaway
In terms of testing devices, the overall industry is broadly bifurcated into laboratory, and point of care devices. The laboratory devices are further divided into flow cytometers, thermal cyclers PCR, differential light scattering machines, lateral flow readers immune-chromatographic assays, and absorbance microplate reader- enzyme-linked immune-sorbent assay (ELISA). Of the laboratory devices, the Lateral Flow Readers category held the highest, over 26%, revenue share in 2019.
Point of care (POC) devices are sub-divided into portable/rapid diagnostic kits, and phone chips (microfluidics + ICT). Among these rapid diagnostic kits accounted for the significant share and is projected to grow with promising CAGR during the forecast period. The integration of advanced technologies, coupled with the growing demand for rapid screening support the segment growth.
Testing Location Takeaway
Based on the testing location, the worldwide STD diagnostics market is divided into PoC, and laboratory testing (private labs, and public health labs). Currently, the laboratory segment captured maximum revenue share owing to the growing number of laboratories, offering STD screening. However, PoCs are anticipated to expand at the fastest growth rate due to its associated benefits compared to laboratories.
Regional Takeaway
Regionally, the overall market is viewed as North America, Middle East & Africa, Asia Pacific, Latin America, and Europe. North America is a dominating region for STD diagnostics owing to the rising prevalence of this infection coupled with favorable government policies for market development. As per the study of the National Center for Biotechnology Information (NCBI), in the U.S. only, more than 20 million sexually transmitted infections (STIs) occur every year and more than half of the cases occur between 1524 year age group. In addition, advancement in technologies to improve the diagnosis & treatment of STD disorders would, in turn, support the regional growth to some extent.
On the flip side, the Asia Pacific region is the fastest-growing market, expanding at over 12% CAGR throughout the study scope. The rapid increase in the prevalence of sexual disorders, coupled with increasing government funding and programs are contributing to the APAC market growth.
COVID-19 Impact
The STD diagnostics market has moderately affected due to the outbreak of COVID-19 all over the globe. The diagnosis of this infection is conducted with special care, similar as the testing of the coronavirus in the patient. Thus, many governments have developed a certain guidelines for avoiding close contact and provided the social distancing rule. Thus, highlighting important developments in the STD Diagnostics field, which are relevant to the current pandemic will help the global market to sustain in the near future.
Key Vendor Takeaway
The leading players of the global STD Diagnostics market include Roche Diagnostics, Danaher Corporation, BioMerieux, Abbott Laboratories, Becton Dickinson and Company, Affymetrix, Inc., Cepheid, Inc., Hologic, Inc., DiaSorin, and Orasure.
Companies are actively involved in strategic mergers and acquisitions to capture a large customer base. In Dec 2017 Becton, Dickinson, and Company has been acquired C. R. Bard, Inc to become the global leader in the process of care for health care and providing treatment of various diseases for patients. This acquisition helped the company to obtain a strong position in the global industry.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year 2015 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2026
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET KEY PLAYERS
Becton Dickinson and Company
Roche Diagnostics
Orasure
Hologic, Inc.
Cepheid Inc.
DiaSorin
Abbott Laboratories
Danaher Corporation
BioMerieux
Affymetrix, Inc.
GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET, BY TYPES
Gonorrhea testing
Herpes Simplex Virus testing
Human Papilloma Virus testing
Human Immunodeficiency Virus testing
Chlamydia testing
Syphilis testing
Chancroid testing
Others
GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET, BY TESTING DEVICE TYPE
Laboratory Devices
Thermal Cyclers PCR
Lateral Flow Readers Immunochromatographic assays
Flow Cytometers
Differential Light Scattering machines
Absorbance microplate reader Enzyme-Linked Immunosorbent Assay (ELISA)
Others
Point of Care (PoC) Devices
Phone chips (microfluidics + ICT)
Portable/benchtop/rapid diagnostic kits
GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET, BY TESTING LOCATION
Point of Care (POC) testing
Laboratory Testing
Commercial/Private labs
Public Health Labs
GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Singapore
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Rest of MEA
TABLE OF CONTENT
1. SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Types
2.1.2. Market Snippet by Testing Device
2.1.3. Market Snippet by Testing Location
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS INDUSTRY STUDY
4.1. Porters Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
4.5. COVID-19 Impact Analysis
4.5.1. Pre-COVID-19 Impact Analysis
4.5.2. Post-COVID-19 Impact Analysis
5. SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET BY TYPES
6.1. Overview
6.1.1. Segment Share Analysis, By Types, 2019 & 2026 (%)
6.2. Gonorrhea Testing
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
6.3. Herpes Simplex Virus Testing
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
6.4. Human Papilloma Virus Testing
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
6.5. Human Immunodeficiency Virus Testing
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
6.6. Chlamydia Testing
6.6.1. Overview
6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
6.7. Syphilis Testing
6.7.1. Overview
6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
6.8. Chancroid Testing
6.8.1. Overview
6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
6.9. Others
6.9.1. Overview
6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7. SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET BY TESTING DEVICE
7.1. Overview
7.1.1. Segment Share Analysis, By Testing Device, 2019 & 2026 (%)
7.2. Laboratory Devices
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7.2.3. Thermal Cyclers PCR
7.2.3.1. Overview
7.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7.2.4. Lateral Flow Readers Immuno chromatographic assays
7.2.4.1. Overview
7.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7.2.5. Flow Cytometers
7.2.5.1. Overview
7.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7.2.6. Differential Light Scattering machines
7.2.6.1. Overview
7.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7.2.7. Absorbance micro plate reader Enzyme Linked Immunosorbent Assay (ELISA)
7.2.7.1. Overview
7.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7.2.8. Others
7.2.8.1. Overview
7.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7.3. Point of Care (PoC) Devices
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7.3.3. Phone chips (micro fluidics + ICT)
7.3.3.1. Overview
7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
7.3.4. Portable/bench top/rapid diagnostic kits
7.3.4.1. Overview
7.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
8. SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET BY TESTING LOCATION
8.1. Overview
8.1.1. Segment Share Analysis, By Testing Location, 2019 & 2026 (%)
8.2. Point of Care (PoC) testing
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
8.3. Laboratory Testing
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
8.3.3. Commercial/Private labs
8.3.3.1. Overview
8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
8.3.4. Public Health Labs
8.3.4.1. Overview
8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9. SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSTICS MARKET BY GEOGRAPHY
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2019 & 2026 (%)
9.2. North America
9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2015 2026 (US$ Million)
9.2.4. North America Market Size and Forecast, By Types, 2015 2026 (US$ Million)
9.2.5. North America Market Size and Forecast, By Testing Device, 2015 2026 (US$ Million)
9.2.6. North America Market Size and Forecast, By Testing Location, 2015 2026 (US$ Million)
9.2.7. U.S.
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.2.8. Canada
9.2.8.1. Overview
9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2015 2026 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Types, 2015 2026 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Testing Device, 2015 2026 (US$ Million)
9.3.6. Europe Market Size and Forecast, By Testing Location, 2015 2026 (US$ Million)
9.3.7. Germany
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.3.8. Italy
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.3.9. United Kingdom
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.3.10. France
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.3.11. Rest of Europe
9.3.11.1. Overview
9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 2026 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Types, 2015 2026 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Testing Device, 2015 2026 (US$ Million)
9.4.6. Asia Pacific Market Size and Forecast, By Testing Location, 2015 2026 (US$ Million)
9.4.7. India
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.4.8. China
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.4.9. Japan
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.4.10. South Korea
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.4.11. Rest of APAC
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2015 2026 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Types, 2015 2026 (US$ Million)
9.5.5. Asia Pacific Market Size and Forecast, By Testing Device, 2015 2026 (US$ Million)
9.5.6. Latin America Market Size and Forecast, By Testing Location, 2015 2026 (US$ Million)
9.5.7. Brazil
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.5.8. Mexico
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.5.9. Argentina
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 2026 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Types, 2015 2026 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Testing Device, 2015 2026 (US$ Million)
9.6.6. Middle East and Africa Market Size and Forecast, By Testing Location, 2015 2026 (US$ Million)
9.6.7. Saudi Arabia
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
9.6.8. United Arab Emirates
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 2026, (US$ Million)
10. KEY VENDOR ANALYSIS
10.1. Cepheid Inc.
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Types Benchmarking
10.1.4. Strategic Initiatives
10.2. Becton Dickinson and Company
10.3. DiaSorin
10.4. Abbott Laboratories
10.5. Roche Diagnostics
10.6. Orasure
10.7. Hologic, Inc.
10.8. Danaher Corporation
10.9. BioMerieux
10.10. Affymetrix, Inc.
11. 360 DEGREE ANALYSTVIEW
12. APPENDIX
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
